Will you have Joint destruction with Naproxen - from FDA reports

Summary

Joint destruction is found among people who take Naproxen, especially for people who are female, 10-19 old also take medication Triamcinolone, and have Rheumatoid arthritis. This study is created by eHealthMe based on reports of 48,538 people who have side effects when taking Naproxen from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on naproxen (the active ingredients of Naproxen) and Naproxen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Joint destruction are also considered in the study.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. (latest outcomes from Naproxen 51,094 users)

What is Joint destruction?

Joint destruction (joint damage) has been reported by people with rheumatoid arthritis, psoriatic arthropathy, psoriasis, high blood pressure, pain (latest reports from 1,045 Joint destruction patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Feb, 27, 2019

48,538 people reported to have side effects when taking Naproxen.
Among them, 20 people (0.04%) have Joint destruction


Number of reports submitted per year:

Could Naproxen cause Joint destruction?

Gender of people who have Joint destruction when taking Naproxen *:

  • female: 94.74 %
  • male: 5.26 %

Age of people who have Joint destruction when taking Naproxen *:

  • 0-1: 0.0 %
  • 2-9: 11.11 %
  • 10-19: 72.22 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 5.56 %
  • 60+: 11.11 %

Top conditions involved for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 18 people, 90.00%
  2. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 10.00%
  3. Neuralgia (pain in one or more nerves): 1 person, 5.00%
  4. Menopause (end of monthly cycles in women): 1 person, 5.00%
  5. High Blood Pressure: 1 person, 5.00%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
  7. Depression: 1 person, 5.00%

Top co-used drugs for these people *:

  1. Triamcinolone: 9 people, 45.00%
  2. Methotrexate: 5 people, 25.00%
  3. Humira: 4 people, 20.00%
  4. Enbrel: 3 people, 15.00%
  5. Orencia: 2 people, 10.00%
  6. Actemra: 2 people, 10.00%
  7. Duexis: 1 person, 5.00%
  8. Benadryl: 1 person, 5.00%
  9. Metformin: 1 person, 5.00%
  10. Folic Acid: 1 person, 5.00%

Top other side effects for these people *:

  1. Diarrhea: 17 people, 85.00%
  2. Weight Loss: 16 people, 80.00%
  3. Septic Shock (shock due to blood infection): 16 people, 80.00%
  4. Nausea And Vomiting: 16 people, 80.00%
  5. Dizziness: 16 people, 80.00%
  6. Nausea (feeling of having an urge to vomit): 16 people, 80.00%
  7. Body Height Below Normal: 16 people, 80.00%
  8. Drug Ineffective: 16 people, 80.00%
  9. Human Antichimeric Antibody Positive: 16 people, 80.00%
  10. Adrenal Insufficiency (condition in which the adrenal glands do not produce adequate amounts of steroids): 16 people, 80.00%

* Approximation only. Some reports may have incomplete information.


Do you have Joint destruction while taking Naproxen?

You are not alone:




Related studies

Drugs that are associated with Joint destruction
Joint destruction (422 drugs)
Could your condition cause Joint destruction
Joint destruction (295 conditions)
Naproxen side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Naproxen
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Naproxen with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Naproxen and have Joint destruction



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.